Medistem Laboratories, Inc. (MDSM) has an rich intellectual property portfolio. From the outset, the Company chose to generate revenues from these assets, by offering licenses of its know-how, trade secrets and intellectual property.
Medistem’s trade secrets and know-how cover ways of generating and practically using adult stem cells in a variety of clinical settings. This licensing program allows modern day stem cell technology, to be utilized in government approved clinics.
Let us hear your thoughts below: